Schedule 13G ownership disclosure

Tenax Therapeutics, Inc.

Security class unavailable · CUSIP: 88032L605

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
372,797
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000669
Form type
SC 13G/A
Filer
Stonepine Capital Management, LLC
CIK
CIK 1440771
Filed
Nov 13, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub